1. KORDELLA XRISA (Xrisa Kordella)
Information acquired: 2025
KORDELLA XRISA is an academic who published a paper in 2018 entitled THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION.